Home

Jeffrey B. Landau, Chief Business Officer: CytomX Therapeutics CTMX Sell · Filed 24/08/22

Trade details

Type
Insider sale
Amount
$5,142.63
Shares · price
4,181 sh · $1.23 a share
Held after
119,056 sh
Trade date
24/08/20
Filed
24/08/22
Days to filing
2 days

Sold 3.4% of holdings

Share of holding sold
3.4%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/21~24/09/19

Jeffrey B. Landau's recent trades

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $13.7K

    Filed 24/03/21

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $5,626

    Filed 23/12/22

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $5,355

    Filed 23/09/22

  • Jeffrey B. Landau

    SellCytomX Therapeutics

    $2,924

    Filed 23/03/20